STOCK TITAN
  1. Home
  2. Financials
  3. NTLA
  4. Revenue

Intellia Therapeutics, Inc (NTLA) Revenue by Year

NTLA

Intellia Therapeutics, Inc generated $67.7M in revenue in fiscal year 2025. This represents an increase of 16.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $59.5M in revenue. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Intellia Therapeutics, Inc has filed alongside them.

FY2025 annual
Revenue $67.7M
YoY +16.9%
5Y CAGR +3.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NTLA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Revenue$59.5M$67.7M+16.9%$57.9M+59.6%$36.3M-30.4%$52.1M+57.7%$33.1M-43.0%$58.0M+34.5%$43.1M+41.6%$30.4M+16.5%$26.1M+58.5%$16.5MN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

NTLA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$7.7M-46.2%$15.0M-9.5%$23.0M+78.8%$13.8M+51.3%$14.2M+104.8%$16.6M-42.5%$12.9M$9.1M-24.0%$7.0M-48.8%$28.9M+129.5%N/A$12.0M-9.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Intellia Therapeutics, Inc financials

Frequently Asked Questions

What was Intellia Therapeutics, Inc's revenue in fiscal year 2025?

Intellia Therapeutics, Inc generated $67.7M in revenue in fiscal year 2025.

How fast is Intellia Therapeutics, Inc's revenue growing?

Intellia Therapeutics, Inc (NTLA) revenue rose by 16.9% year over year, from $57.9M to $67.7M in fiscal year 2025.

What is Intellia Therapeutics, Inc's revenue over the last twelve months?

Intellia Therapeutics, Inc (NTLA) reported $59.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Intellia Therapeutics, Inc (NTLA) reported $7.7M in revenue in Q2 2026. This represents a decrease of 46.2% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Intellia Therapeutics, Inc (NTLA) reported on that line in every period on record.